[{"orgOrder":0,"company":"Itonis","sponsor":"Caring Brands","pharmaFlowCategory":"D","therapeuticArea":"Gastroenterology","country":"U.S.A","productType":"Plant Extract\/Herbal","year":"2026","type":"Licensing Agreement","leadProduct":"Ipecacuanha Liquid Extract","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Approved FDF","graph3":"Itonis","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Spray","sponsorNew":"Itonis \/ Caring Brands","highestDevelopmentStatusID":"15","companyTruncated":"Itonis \/ Caring Brands"}]

Find Clinical Drug Pipeline Developments & Deals for Ipecac

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Itonis

                          Country arrow
                          BIO Partnering at JPM
                          Not Confirmed

                          Itonis

                          Country arrow
                          BIO Partnering at JPM
                          Not Confirmed

                          Details : Through the licensing deal for Ipecacuanha, the agreement aims to address nausea with a plant extract/herbal product.

                          Product Name : Emesyl

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Undisclosed

                          January 05, 2026

                          Lead Product(s) : Ipecacuanha Liquid Extract,Tabacum,Zingiber officinale

                          Therapeutic Area : Gastroenterology

                          Highest Development Status : Approved FDF

                          Sponsor : Caring Brands

                          Deal Size : Undisclosed

                          Deal Type : Licensing Agreement

                          blank